The FDA approved mFlusiva, the first mRNA-based influenza vaccine, for adults 50 years and older with accelerated approval for those 65 and older.

Health officials launched a nationwide trial to find out whether a drug used to treat diabetes can help veterans with alcohol use disorder.

Two Michigan residents have died in a widening outbreak of cyclosporiasis, the first deaths from this parasite ever confirmed in the US.

A retrospective study shows rising sepsis-related mortality in older adults with influenza or pneumonia, peaking in 2021.

The 2024-2025 US influenza vaccine provided moderate protection against outpatient illness, reducing medically attended visits by one-third.

The FDA has accepted for Priority Review the New Drug Application for D-PLEX100 for the prevention of SSIs in patients undergoing surgery.

Postoperative risks for sepsis and pulmonary embolism are highest when joint arthroplasty occurs within 4 weeks of COVID-19 diagnosis.

The FTC has sued telehealth company Hims & Hers, alleging it shared consumers' private health information with advertising platforms.

Many young adults may be entering adulthood without the skills needed to manage their own health care, according to a recent survey.

Disease-specific immune trajectories are identified years before onset of inflammatory bowel disease, according to results of a recent study.

Women with long COVID experience higher neurologic symptom burden and worse fatigue than men, regardless of hospitalization status.

Filgotinib may be associated with a lower risk of herpes zoster compared with other Janus kinase inhibitors in rheumatoid arthritis.